Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans

NCT04237792 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

MRI Sedation

Interventions

DRUG: dexmedetomidine
DRUG: propofol

Sponsor

Pfizer